Monitoring renal function in patients treated with cytostatics;Måling af nyrefunktion under cytostatisk behandling

Ugeskrift for Laeger

Volumn 170, Issue 45, 2008, Pages

  Hartlev, Louise Brøndt ^a   Rotbøl, Charlotte Bøje ^a   Bluhme, Henrik ^a   Palshof, Torben ^a   Rehling, Michael ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHROMIUM; CREATININE; DIAGNOSTIC AGENT; EDETIC ACID;

ADULT; AGED; ARTICLE; BLOOD; DRUG EFFECT; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY; MALE; METABOLISM; MIDDLE AGED; NEOPLASM; RETROSPECTIVE STUDY;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CHROMIUM RADIOISOTOPES; CREATININE; EDETIC ACID; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 55949118557     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Ekhart C, de Jonge ME, Huitema AD et al. Flat dosing of carboplatin is justified in adult patients with normal renal function. Clin Cancer Res 2006;12:6502-8.
2. Springate JE. Ifosfamide metabolite chloroacetaldehyde causes renal dysfunction in vivo. J Appl Toxicol 1997;17:75-9.
3. Zaki EL, Springate JE, Taub M. Comparative toxicity of ifosfamide metabolites and protective effect of mesna and amifostinein cultured renal tubule cells. Toxicol In Vitro 2003;17:397-402.
4. Lichtman SM, Wildiers H, Launay-Vacher V et al. International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency. Eur J Cancer 2007;43:14-34.
5. Yao X, Panichpisal K, Kurtzman N et al. Cisplatin nephrotoxicity: a review. Am J Med Sci 2007;334:115-24.
6. Taguchi T, Nazneen A, Abid MR et al. Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol 2005;148:107-21.
7. Kampmann J, Siersbaek-Nielsen K, Kristensen M et al. Rapid evaluation of creatinine clearance. Acta Med Scand 1974;196:517-20.
8. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
9. 61Cr-EDTA clearance determined by one plasma sample. Clin Physiol 1981;1:417-25.
10. DuBois D, DuBois EF. Clinical calorimetry. X. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916;17:863-71.
11. Rehling M, Stadeager C, Henriksen JH et al. Measurement of glomerular filtration rate in patients with ascites, I: Thomsen HS, Nally JP, Jr., Britton K, Frøkiær J, eds. Radionuclides in Nephrourology. København: FADL, 1998:114-18.